Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 158

Related Articles by Review for PubMed (Select 18715219)

1.

Role of emerging new technologies.

Garg SK.

Diabetes Technol Ther. 2008 Oct;10(5):413-4. doi: 10.1089/dia.2008.0069. No abstract available.

PMID:
18715219
2.

[How should we use the short-acting insulin analog Lys-Pro in external continuous subcutaneous pumps?].

Guerci B, Jeandidier N, Lassmann-Vague V, Renard E, Hanaire-Broutin H.

Diabetes Metab. 2000 Dec;26(6):513-9. Review. French. Erratum in: Diabetes Metab 2001 Feb;27(1):86.

3.

Insulin therapy in the management of type 1 and type 2 diabetes.

Wallymahmed M.

Nurs Stand. 2006 Oct 18-24;21(6):50-6; quiz 58. Review.

PMID:
17069159
4.

Insulin therapy in children and adolescents.

Tamborlane WV, Sikes KA.

Endocrinol Metab Clin North Am. 2012 Mar;41(1):145-60. doi: 10.1016/j.ecl.2012.01.002. Epub 2012 Feb 24. Review.

PMID:
22575411
5.

Emerging diabetes therapies and technologies.

Moser EG, Morris AA, Garg SK.

Diabetes Res Clin Pract. 2012 Jul;97(1):16-26. doi: 10.1016/j.diabres.2012.01.027. Epub 2012 Feb 29. Review.

PMID:
22381908
6.

[The diabetic child and the specifics of insulin therapy].

Dirlewanger M, Perrenoud L, Castellsague-Perolini M, Schwitzgebel VM.

Rev Med Suisse. 2007 Apr 18;3(107):994-1000. Review. French.

PMID:
17526373
7.

Intensified insulin therapy.

Amiel SA.

Diabetes Metab Rev. 1993 Apr;9(1):3-24. Review. No abstract available.

PMID:
8344121
8.

Alternative insulin delivery systems: how demanding should the patient be?

Polonsky KS, Byrne MM, Sturis J.

Diabetologia. 1997 Jul;40 Suppl 2:S97-101. Review. No abstract available.

PMID:
9248709
9.

Emerging care for type 2 diabetes: using insulin to reach lower glycemic goals.

Feinglos MN, Bethel MA.

Cleve Clin J Med. 2005 Sep;72(9):791-9. Review.

PMID:
16193826
10.

[Control of diabetes mellitus].

Daweke H.

Verh Dtsch Ges Inn Med. 1990;96:175-82. Review. German. No abstract available.

PMID:
2092437
11.

Glycemic management of diabetes by insulin therapy.

Reix N, Sigrist S, Heurtault B, Agin A, Moreau F, Pinget M, Jeandidier N.

Minerva Endocrinol. 2013 Mar;38(1):29-46. Review.

PMID:
23435441
12.

Future developments in insulin pump therapy: progression from continuous subcutaneous insulin infusion to a sensor-pump system.

Fisher LK, Halvorson M.

Diabetes Educ. 2006 Jan-Feb;32(1 Suppl):47S-52S. Review. No abstract available.

PMID:
16439491
13.

The use of insulin pump therapy in the pediatric age group.

Shalitin S, Phillip M.

Horm Res. 2008;70(1):14-21. doi: 10.1159/000129673. Epub 2008 May 21. Review.

14.

Clinical requirements for closed-loop control systems.

Clarke WL, Renard E.

J Diabetes Sci Technol. 2012 Mar 1;6(2):444-52. Review.

15.
16.

Assessment and monitoring of glycemic control in children and adolescents with diabetes.

Rewers M, Pihoker C, Donaghue K, Hanas R, Swift P, Klingensmith GJ.

Pediatr Diabetes. 2009 Sep;10 Suppl 12:71-81. doi: 10.1111/j.1399-5448.2009.00582.x. Review. No abstract available.

PMID:
19754620
17.

Quality of life and technology: impact on children and families with diabetes.

Hirose M, Beverly EA, Weinger K.

Curr Diab Rep. 2012 Dec;12(6):711-20. doi: 10.1007/s11892-012-0313-4. Review.

18.

Inferences and implications. Do results from the Diabetes Control and Complications Trial apply in NIDDM?

Nathan DM.

Diabetes Care. 1995 Feb;18(2):251-7. Review. No abstract available.

PMID:
7729307
19.

[Hypoglycemia in diabetic children].

Tupola S, Rajantie J.

Duodecim. 2000;116(2):125-31. Review. Finnish. No abstract available.

PMID:
11764469
20.

Reassessment of insulin dosing guidelines in continuous subcutaneous insulin infusion treated type 1 diabetes.

King AB.

Curr Diab Rep. 2014 Jun;14(6):503. doi: 10.1007/s11892-014-0503-3. Review.

PMID:
24792068
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk